{"id":"https://openalex.org/W2587021669","doi":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","title":"Mathematical Models of Cancer Evolution and Cure","display_name":"Mathematical Models of Cancer Evolution and Cure","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2587021669","doi":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","mag":"2587021669"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.sci-54.sci-54","doi":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091861581","display_name":"Franziska Michor A","orcid":"https://orcid.org/0000-0003-4869-8842","observed_orcids":["https://orcid.org/0000-0003-4869-8842","https://orcid.org/0009-0003-8552-7767"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Franziska Michor","raw_affiliation_strings":["Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091861581"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34827845,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"SCI","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/mathematical-tumor-growth-model","display_name":"mathematical tumor growth model","score":0.6449999809265137},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9089999794960022},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.8389999866485596},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.703000009059906},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7885622978210449},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6452810168266296},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5189483165740967},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5109385848045349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47960197925567627},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.45931604504585266},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.44887781143188477},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.42752695083618164},{"id":"https://openalex.org/C113968399","wikidata":"https://www.wikidata.org/wiki/Q7559241","display_name":"Somatic evolution in cancer","level":3,"score":0.4259486794471741},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4210607409477234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3939129114151001},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.32477453351020813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2928808331489563},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.sci-54.sci-54","doi":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.sci-54.sci-54","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2302632356","https://openalex.org/W2982266106","https://openalex.org/W2277710605","https://openalex.org/W2279947143","https://openalex.org/W7137465193","https://openalex.org/W1985006219","https://openalex.org/W4241008209","https://openalex.org/W4310120201","https://openalex.org/W2556053110","https://openalex.org/W2609004154"],"abstract_inverted_index":{"Abstract":[0],"Since":[1],"the":[2,9,92,175,203,220],"pioneering":[3],"work":[4],"of":[5,11,15,41,65,77,94,135,144,153,223,233],"Salmon":[6],"and":[7,29,59,102,119,140,170],"Durie,":[8],"availability":[10],"a":[12,38,61,88,132,141,160,166,194,215],"quantitative":[13],"measure":[14],"malignant":[16],"cell":[17,33,67,97],"burden":[18],"in":[19,80,179,226],"multiple":[20,227],"myeloma":[21,116,124,198],"has":[22],"been":[23],"used":[24],"to":[25,30,57,72,151,235],"make":[26],"clinical":[27,49,183],"predictions":[28],"model":[31,64,90,130,150,163,212],"tumor":[32,42,96,176],"growth.":[34],"Here,":[35],"we":[36,157],"analyzed":[37],"large":[39],"set":[40],"response":[43,79,177],"data":[44,152],"from":[45],"three":[46],"randomized":[47],"controlled":[48],"trials":[50],"(total":[51],"sample":[52],"size":[53],"n=1,469":[54],"evaluable":[55],"patients)":[56],"establish":[58],"validate":[60],"novel":[62],"mathematical":[63,89,162,187],"MM":[66,138,155,167],"dynamics":[68],"based":[69],"on":[70,115,123,197],"responses":[71,108],"bortezomib-based":[73,191],"chemotherapy":[74,224],"regimens.":[75],"Dynamics":[76],"treatment":[78,107],"newly":[81,136],"diagnosed":[82,137],"patients":[83,139],"were":[84,109],"most":[85],"consistent":[86],"with":[87,111,186],"postulating":[91],"existence":[93],"two":[95],"subpopulations,":[98],"\"myeloma":[99,103],"progenitor":[100,125],"cells\"":[101],"differentiated":[104,117],"cells\".":[105],"Differential":[106],"observed":[110],"significant":[112],"tumoricidal":[113],"effects":[114,122],"cells":[118,199],"less":[120],"clear":[121],"cells.":[126],"We":[127],"validated":[128],"this":[129],"using":[131],"second":[133],"trial":[134,143],"third":[142],"refractory":[145],"patients.":[146,181],"When":[147],"applying":[148],"our":[149],"relapsed":[154],"patients,":[156],"found":[158],"that":[159,190,200],"hybrid":[161],"incorporating":[164],"both":[165],"differentiation":[168],"hierarchy":[169],"clonal":[171],"evolution":[172],"best":[173],"explains":[174],"patterns":[178],"all":[180],"The":[182],"data,":[184],"together":[185],"modeling,":[188],"suggest":[189],"therapy":[192],"exerts":[193],"selection":[195],"pressure":[196],"can":[201],"shape":[202],"disease":[204],"phenotype,":[205],"thereby":[206],"generating":[207],"further":[208],"inter-patient":[209],"variability.":[210],"This":[211],"may":[213],"be":[214],"useful":[216],"tool":[217],"for":[218],"improving":[219],"rational":[221],"design":[222],"regimens":[225],"myeloma.":[228],"Disclosures":[229],"No":[230],"relevant":[231],"conflicts":[232],"interest":[234],"declare.":[236]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-17T00:00:00"}